Trial NCT02203513

View at ClinicalTrials.gov 
Org. Study IDs: 140156
Secondary IDs: 14-C-0156

Last trial update was posted on 2022-09-10

MeSH Interventions

Prexasertib

MeSH Conditions

Breast Neoplasms Carcinoma, Ovarian Epithelial Ovarian Neoplasms Prostatic Neoplasms Triple Negative Breast Neoplasms

Other Conditions

Breast Cancer Ovarian Cancer Prostate Cancer

Stopping Reasons

Eli Lilly prematurely terminated the study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID